Daily Intelligence Brief
Weekly Docket: Talc, Depo-Provera, and Hair Relaxer Drive 347 New Filings
LexGenius tracked 347 new federal filings over the past week, with volume concentrated in four pharmaceutical and consumer-product dockets. The Johnson & Johnson Talcum Powder Products Liability Litigation (MDL 2738) led with 50 new cases, paced by The Smith Law Firm PLLC (14), Wagstaff Law Firm (11), and Trammell PC (9). Close behind, the Depo-Provera Products Liability Litigation (MDL 3140) logged 46 new suits, with Weitz & Luxenberg PC and Seeger Weiss each filing 10. The Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL 3060) added 41 cases across a broader plaintiff bar including Morgan & Morgan PA, Wallace Miller, and Dicello Levitt LLP, while the Social Media Adolescent Addiction Personal Injury Products Liability Litigation (MDL 3047) contributed 33 filings, dominated by Law Offices of Charles H Johnson PA (16).Abbott Hit With $70M NEC Verdict as Preterm Formula MDL Gains Trial Momentum
A St. Louis jury ordered Abbott Laboratories to pay $70 million in a bellwether-style trial over its Similac preterm infant formula, finding the company failed to warn parents of a link between cow's-milk-based preterm formula and necrotizing enterocolitis. The verdict in the Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation follows an earlier $53 million award reported days before and sets an aggressive damages benchmark heading into the next wave of trials. Abbott has signaled it will appeal, but plaintiffs' counsel are already citing the verdict in MDL briefing to pressure consolidated resolution. Commentators flagged the award as a potential inflection point for the roughly 1,000 NEC cases pending across federal and state courts, and a likely accelerant for global-settlement discussions.Texas AG Sues Lululemon Over PFAS, Opening New Consumer-Product Front in "Forever Chemicals" Litigation
Texas Attorney General Ken Paxton filed suit against Lululemon Athletica Inc. and opened a parallel investigation into the company's alleged use of per- and polyfluoroalkyl substances (PFAS) in activewear, marking the first state-AG consumer-fraud action targeting an apparel brand for "forever chemicals." The complaint, filed in Texas state court, alleges Lululemon misrepresented its products as safe and sustainable despite internal knowledge of PFAS content — a theory that mirrors the deception claims driving ongoing food-packaging and cosmetics PFAS suits. Lululemon publicly responded that it phased out the challenged chemistries, but that denial is unlikely to moot the AG's investigative demands. The filing lands as Maine tightens drinking-water PFAS limits and municipalities including Hermiston, Oregon and Sioux City, Iowa move to join or settle existing water-contamination claims, suggesting a widening regulatory and plaintiff pincer on PFAS defendants outside the AFFF MDL.Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
